1. Home
  2. BOLD vs BTCT Comparison

BOLD vs BTCT Comparison

Compare BOLD & BTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • BTCT
  • Stock Information
  • Founded
  • BOLD 2018
  • BTCT 2006
  • Country
  • BOLD United States
  • BTCT Singapore
  • Employees
  • BOLD N/A
  • BTCT N/A
  • Industry
  • BOLD
  • BTCT Other Consumer Services
  • Sector
  • BOLD
  • BTCT Real Estate
  • Exchange
  • BOLD Nasdaq
  • BTCT Nasdaq
  • Market Cap
  • BOLD 24.4M
  • BTCT 19.8M
  • IPO Year
  • BOLD 2024
  • BTCT N/A
  • Fundamental
  • Price
  • BOLD $1.19
  • BTCT $2.76
  • Analyst Decision
  • BOLD Buy
  • BTCT
  • Analyst Count
  • BOLD 3
  • BTCT 0
  • Target Price
  • BOLD $4.00
  • BTCT N/A
  • AVG Volume (30 Days)
  • BOLD 105.5K
  • BTCT 1.8M
  • Earning Date
  • BOLD 08-11-2025
  • BTCT 08-13-2025
  • Dividend Yield
  • BOLD N/A
  • BTCT N/A
  • EPS Growth
  • BOLD N/A
  • BTCT N/A
  • EPS
  • BOLD N/A
  • BTCT N/A
  • Revenue
  • BOLD N/A
  • BTCT $11,675,000.00
  • Revenue This Year
  • BOLD N/A
  • BTCT $13.58
  • Revenue Next Year
  • BOLD N/A
  • BTCT N/A
  • P/E Ratio
  • BOLD N/A
  • BTCT N/A
  • Revenue Growth
  • BOLD N/A
  • BTCT 28.68
  • 52 Week Low
  • BOLD $1.00
  • BTCT $1.32
  • 52 Week High
  • BOLD $4.72
  • BTCT $26.58
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • BTCT 38.56
  • Support Level
  • BOLD N/A
  • BTCT $3.00
  • Resistance Level
  • BOLD N/A
  • BTCT $3.25
  • Average True Range (ATR)
  • BOLD 0.00
  • BTCT 0.38
  • MACD
  • BOLD 0.00
  • BTCT -0.07
  • Stochastic Oscillator
  • BOLD 0.00
  • BTCT 2.87

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. The company is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the unmet need in patients with oncogene-amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About BTCT BTC Digital Ltd.

BTC Digital Ltd is a crypto asset technology company based in the U.S. with a focus on bitcoin mining. The company also generates revenue through mining machine resale and rental business operations. Geographically, the financial assets of the company is located in the United States, Singapore, Hong Kong and the PRC.

Share on Social Networks: